Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 5 December 2008, doi:10.1136/bmj.a2896
Cite this as: BMJ 2008;337:a2896
Madeleine Brettingham
1 London
| The first 150 words of the full text of this article appear below. |
A stem cell therapy that repairs damaged cells after a heart attack, injectable bone that can be used to fill voids in bone, and a technique to determine which patients will respond to drugs in development were among the winners at an award ceremony for medical innovation held on 2 December in London by the Medical Futures group.
The stem cell therapy, developed by a team at the National Heart and Lung Institute at Imperial College London, aims to take stem or progenitor cells from a patients heart muscle, grow them in the laboratory, and then graft them back into the injured muscle.
The team, comprising Michael Schneider, Dorian Haskard, and Ranil de Silva, won the cardiovascular innovation award. Professor Schneider was also recently awarded a grant of £2.5m by the European Research Council for his work in this area (BMJ 2008;337:a2816, 1 Dec, doi:10.1136/bmj.a2816).
"There is
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?